Inflammatory response in acute viral exacerbations of COPD

Infection

Volumn 36, Issue 5, 2008, Pages 427-433

  Rohde, G ^a   Borg, I ^a,b   Wiethege, A ^a   Kauth, M ^a   Jerzinowski, S ^a   An Duong Dinh, T ^a   Bauer, T T ^c   Bufe, A ^b   Schultze Werninghaus, G ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Respiratory Diseases Clinic Heckeshorn   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LAVAGE; LEUKOCYTE COUNT; LUNG INFECTION; MACROPHAGE; MALE; NEUTROPHIL COUNT; NOSE MUCUS; PROTEIN BLOOD LEVEL; RESPIRATORY VIRUS; SPUTUM ANALYSIS; SPUTUM LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIRUS DETECTION; VIRUS INFECTION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 56549099808     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7327-5     Document Type: Article

References (30)

1. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
2. Sethi S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117: 380S-385S.
3. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173: 1114-1121.
4. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
5. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization - a case-control study. Thorax 2003; 58: 37-42.
6. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha JA: Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55: 114-120.
7. Roland M, Bhowmik A, Sapsford RJ, Seemungal TAR, Jeffries DJ, Warner TD, Wedzicha JA: Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001; 56: 30-35.
8. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE: Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349-355.
9. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W: Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005; 60: 293-300.
10. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K: Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 640-646.
11. Wedzicha JA, Seemungal TAR, McCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW: Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-215.
12. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Buurman WA, Wouters EF: Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56: 721-726.
13. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
14. Hansell AL, Walk JA, Soriano JB: What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
15. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA: Systemic, upper and lower airway inflammation at exacerbation of COPD. Am J Respir Crit Care Med 2005; 173: 71-78.
16. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
17. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
18. Pavord ID, Pizzichini M, Pizzichini E, Hargreave FE: The use of induced sputum to investigate airway inflammation. Thorax 1997; 52: 498-501.
19. Holz O, Richter K, Jörres RA, Speckin P, Mücke M, Magnussen H: Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998; 53: 83-86.
20. Stevenson NJ, Walker PP, Costello RW, Calverley PMA: Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1510-1516.
21. Hogg JC: Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
22. Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA, Warner JA: MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 6: 151.
23. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G , Fabbri LM: Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26: 766-774.
24. Barczyk A, Pierzchala W, Kon OM, Cosio B, Adcock IM, Barnes PJ: Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006; 117: 1484-1492.
25. Kang MJ, Lee CG, Cho SJ, Homer RJ, Elias JA: IFN-gamma-dependent DNA injury and/or apoptosis are critical in cigarette smoke-induced murine emphysema. Proc Am Thorac Soc 2006; 3: 517-518.
26. Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA: Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 71-78.
27. Daldegan MB, Teixeira MM, Talvani A: Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. Braz J Med Biol Res 2005; 38: 1359-1365.
28. Fleming HE, Little FF, Schnurr D, Avila PC, Wong H, Liu J, Yagi S, Boushey HA: Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999; 160: 100-108.
29. Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96: 549-557.
30. Rohde G, Schultze-Werninghaus G, Bauer TT: Treatment for viral respiratory infections: principles of action, strategies, and future prospects. Internist 2004; 45: 468-475.